Annual report pursuant to Section 13 and 15(d)

Cash Equivalents and Investments (Schedule of Cash Equivalents and Available-for-Sale Securities) (Details)

v3.10.0.1
Cash Equivalents and Investments (Schedule of Cash Equivalents and Available-for-Sale Securities) (Details) - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost   $ 11,735,000
Gross Unrealized Losses $ 0 (1,000)
Fair Value   11,734,000
Cash Equivalents   6,193,000
Short-Term Investments   5,540,744
Long-Term Investments  
Cash Equivalents [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 8,428,000 6,193,000
Fair Value 8,428,000 6,193,000
Cash Equivalents 8,428,000 6,193,000
Cash Equivalents [Member] | Money Market Funds [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 8,428,000 6,193,000
Fair Value 8,428,000 6,193,000
Cash Equivalents $ 8,428,000 6,193,000
Investments [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost   5,542,000
Gross Unrealized Losses   (1,000)
Fair Value   5,541,000
Short-Term Investments   5,541,000
Investments [Member] | Commercial Paper [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost   997,000
Fair Value   997,000
Short-Term Investments   997,000
Investments [Member] | Corporate Notes/Bonds [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost   4,545,000
Gross Unrealized Losses   (1,000)
Fair Value   4,544,000
Short-Term Investments   $ 4,544,000